Hanne van Ballegooijen1, Lucas Goossens2, Ralph H Bruin3, Renée Michels3, Marieke Krol3. 1. IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com. 2. Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. 3. IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands.
Abstract
BACKGROUND: The COVID-19 pandemic has a disruptive impact on our society. We therefore conducted a population survey to describe: 1) stress, concerns and quality of life 2) access to healthcare and cancelled/delayed healthcare and 3) productivity during the first 8 weeks of the coronavirus lockdown in the general population. METHODS: An online cross-sectional survey was conducted in a representative sample after 8 weeks of the coronavirus lockdown in Belgium and the Netherlands. The survey included a series of three validated questionnaires about quality of life delayed/cancelled medical care and productivity loss using validated questionnaires. RESULTS: In total, 2099 Belgian and 2058 Dutch respondents completed the survey with a mean age of 46.4 and 42.0 years, respectively. Half of the respondents were female in both countries. A small proportion tested positive for COVID-19, 1.4% vs 4.7%, respectively. The majority of respondents with a medical condition was worried about their current health state due to the pandemic (53%) vs (63%), respectively. Respondents experienced postponed/cancelled care (26%) and were concerned about the availability of medication (32%) for both countries. Productivity losses due to the COVID-19 restrictions were calculated in absenteeism (36%) and presenteeism (30%) for Belgium, and (19%) and (35%) for the Netherlands. Most concerns and productivity losses were reported by respondents with children < 12 years, respondents aged 18-35 and respondents with an (expected) COVID-19 infection. CONCLUSIONS: This study describes stress, quality of life, medical resource loss and productivity losses in Belgium and the Netherlands after 8 weeks of coronavirus lockdown. The results underline the burden on society.
BACKGROUND: The COVID-19 pandemic has a disruptive impact on our society. We therefore conducted a population survey to describe: 1) stress, concerns and quality of life 2) access to healthcare and cancelled/delayed healthcare and 3) productivity during the first 8 weeks of the coronavirus lockdown in the general population. METHODS: An online cross-sectional survey was conducted in a representative sample after 8 weeks of the coronavirus lockdown in Belgium and the Netherlands. The survey included a series of three validated questionnaires about quality of life delayed/cancelled medical care and productivity loss using validated questionnaires. RESULTS: In total, 2099 Belgian and 2058 Dutch respondents completed the survey with a mean age of 46.4 and 42.0 years, respectively. Half of the respondents were female in both countries. A small proportion tested positive for COVID-19, 1.4% vs 4.7%, respectively. The majority of respondents with a medical condition was worried about their current health state due to the pandemic (53%) vs (63%), respectively. Respondents experienced postponed/cancelled care (26%) and were concerned about the availability of medication (32%) for both countries. Productivity losses due to the COVID-19 restrictions were calculated in absenteeism (36%) and presenteeism (30%) for Belgium, and (19%) and (35%) for the Netherlands. Most concerns and productivity losses were reported by respondents with children < 12 years, respondents aged 18-35 and respondents with an (expected) COVID-19infection. CONCLUSIONS: This study describes stress, quality of life, medical resource loss and productivity losses in Belgium and the Netherlands after 8 weeks of coronavirus lockdown. The results underline the burden on society.
Entities:
Keywords:
Burden of disease; COVID-19; Coronavirus; Medical resource use; Population survey; Productivity; Quality of life
Authors: Matthijs M Versteegh; Karin M Vermeulen; Silvia M A A Evers; G Ardine de Wit; Rilana Prenger; Elly A Stolk Journal: Value Health Date: 2016-03-30 Impact factor: 5.725
Authors: Helen C Johnson; Céline M Gossner; Edoardo Colzani; John Kinsman; Leonidas Alexakis; Julien Beauté; Andrea Würz; Svetla Tsolova; Nick Bundle; Karl Ekdahl Journal: Euro Surveill Date: 2020-03
Authors: Nádia Nara Rolim Lima; Ricardo Inácio de Souza; Pedro Walisson Gomes Feitosa; Jorge Lucas de Sousa Moreira; Claudio Gleidiston Lima da Silva; Modesto Leite Rolim Neto Journal: Psychiatry Res Date: 2020-04-11 Impact factor: 3.222
Authors: Samantha K Brooks; Rebecca K Webster; Louise E Smith; Lisa Woodland; Simon Wessely; Neil Greenberg; Gideon James Rubin Journal: Lancet Date: 2020-02-26 Impact factor: 79.321
Authors: Louise T C Mulder; Martine Busch; Agnete E Kristoffersen; Johanna Hök Nordberg; Esther T van der Werf Journal: BMC Complement Med Ther Date: 2022-02-15